Comparison |
Alternate Manufacturer Number |
3956455 | | | | |
Alternate Packaging |
| | CT/5 | BX/25 | EA/1 |
Container Type |
Bottle | Ampule | Single-Dose Vial | Single-Dose Vial | Single-Dose Vial |
Country of Origin |
India | Unknown | Unknown | Unknown | Italy |
Dosage Form |
Tablet | Injection | Injection | Injection | Injection |
Generic Drug Code |
32471 | 02331 | 01650 | 01650 | 01650 |
Generic Drug Name |
Verapamil HCl | Verapamil HCl | Verapamil HCl, Preservative Free | Verapamil HCl, Preservative Free | Verapamil HCl, Preservative Free |
Latex Free Indicator |
| Not Made with Natural Rubber Latex | | | |
NDC Number |
75834015801 | 00409401101 | 00409114402 | 00409114405 | 51662126903 |
Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | | McKesson Acceptable Dating: we will ship >= 90 days | | McKesson Acceptable Dating: we will ship >= 90 days |
Quantity |
100 Tablets | | | | |
Strength |
180 mg | 2.5 mg / mL | 2.5 mg / mL | 2.5 mg / mL | 2.5 mg / mL |
Type |
Extended Release | Intravenous | Intravenous | Intravenous | Intravenous |
Volume |
| 2 mL | 4 mL | 2 mL | 2 mL |
Application |
Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent | Calcium-Channel Blocking Agent |
UNSPSC Code |
51431614 | 51431614 | 51431614 | 51431614 | 51431614 |
Features and Benefits |
|
|
- Single dose glass flip-top vial
|
- Single dose glass fliptop vial
- Verapamil hydrochloride is a calcium antagonist or slow-channel inhibitor
- The solution contains no bacteriostat or antimicrobial agent and is intended for single-dose intravenous administration
- The antiarrhythmic effect of verapamil appears to be due to its effect on the slow channel in cells of the cardiac conduction system
- The vasodilatory effect of verapamil appears to be due to its effect on blockade of calcium channels as well as receptors
|
- Verapamil hydrochloride is a calcium antagonist or slow-channel inhibitor
- The solution contains no bacteriostat or antimicrobial agent and is intended for single-dose intravenous administration
- The antiarrhythmic effect of verapamil appears to be due to its effect on the slow channel in cells of the cardiac conduction system
- The vasodilatory effect of verapamil appears to be due to its effect on blockade of calcium channels as well as receptors
|